A Study to Evaluate the Effect of Formulation and Food on Calderasib (MK-1084) in Healthy Adult Participants (MK-1084-011)
Clinical trial NCT06942741 · COMPLETED
Trial details
- NCT number
- NCT06942741
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-13
- Primary completion
- 2025-06-22
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.